Answers are grounded in this paper and cite their sources.
BackgroundIn December 2019, a cluster of cases of acute respiratory illness, novel coronavirus-infected pneumonia, occurred in Wuhan, Hubei Province, China. Health care workers exposure to a high density of patients are at extremely high risk of becoming infected at the early outbreak of this disease for not realizing the fact of human-to-human transmission among close contacts at that time. The false-negative nasopharyngeal swabs of SARS-CoV-2 caused the delayed diagnosis of COVID-19. The nosocomial transmission of SARS-CoV-2 in negative nasopharyngeal swabs cases were not reported previously. We wish to alert the potential transmission risk in COVID-19 patients with negative swab tests to the clinicians and stress the role of serological detection of anti-SARS-CoV-2.MethodsThis study evaluated a total of 6 cases and four of them were health care providers who worked in the same ward. All epidemiological and clinical information was collected. Respiratory samples of the patients were tested for influenza A, influenza B and respiratory syncytial virus (RSV) RNA The reverse-transcription–polymerase chain reaction (RT-PCR) assay of SARS-CoV-2 RNA was conducted and serological detection of anti-SARS-CoV-2-IgG/IgM is performed by chemiluminescence immunoassay kit.ResultsWe reported two related clusters of COVID-19 cases. The first cluster is a nosocomial infection of four health care providers at early January in one ward of university hospital. One of them made sequential familial cluster of infection. For total six cases, four of them (66.7%) showed negative RNA of SARS-CoV-2 by nasopharyngeal swabs. All patients received either self-quarantined at home or were admitted to hospital for isolated treatment. All recovered and had anti-SARS-CoV-2 IgG and/or IgM positive (100%) for serological detection of SARS-CoV-2 at recovery stage.ConclusionsOur study provides a cautionary warning that negative results of nasopharyngeal swabs of suspected SARS-CoV-2 infection can increase the risk of nosocomial infection among health care providers. Serologic detection for anti-SARS-CoV-2 IgG and/or IgM is an important test in the assistant diagnosis of COVID-19.
No takes yet. Share an insight, caveat, or question.
Cao et al. (2020) studied this question.